CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-29 | Tammara Vijay Senior Vice President | Option exercise | +5,111 | $0.57 | $3K | 5,111 |
| 2021-04-29 | Tammara Vijay Senior Vice President | Sale | −5,111 | $10.96 | $56K | 0 |
| 2021-04-29 | Tammara Vijay Senior Vice President | Option exercise · Options (Right to Buy) | −9,000 | 9,217 | ||
| 2021-04-29 | Tammara Vijay Senior Vice President | Option exercise · Options (Right to Buy) | −3,000 | 4,191 | ||
| 2021-04-29 | Tammara Vijay Senior Vice President | Option exercise · Options (Right to Buy) | −12,880 | 64,761 | ||
| 2021-04-29 | Tammara Vijay Senior Vice President | Option exercise · Options (Right to Buy) | −5,111 | 44,889 | ||
| 2021-04-26 | Kompella Uday Director | Sale | −350,000 | $11.70 | $4.1M | 600,674 |
| 2021-04-19 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2021-04-19 | Kumar Ramesh Director | Sale | −7,500 | $5.33 | $40K | 0 |
| 2021-04-19 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | −7,500 | 46,500 | ||
| 2021-03-05 | Potti Manish Director | Option exercise | +21,000 | $0.51 | $11K | 21,000 |
| 2021-03-05 | Potti Manish Director | Option exercise | +7,000 | $1.83 | $13K | 28,000 |
| 2021-03-05 | Potti Manish Director | Option exercise · Option (Right to Buy) | −21,000 | 33,000 | ||
| 2021-03-05 | Potti Manish Director | Option exercise · Oprion (Right to Buy) | −7,000 | 119,000 | ||
| 2021-01-29 | Subramanian Sanjay Chief Financial Officer | Option exercise | +35,591 | $0.51 | $18K | 45,591 |
| 2021-01-29 | Subramanian Sanjay Chief Financial Officer | Option exercise · Option (Right to Buy) | −35,591 | 71,183 | ||
| 2021-01-01 | Tammara Vijay Senior Vice President | Grant or award · Option (Right to Buy) | +220,500 | 220,500 | ||
| 2021-01-01 | Kompella Uday Director | Grant or award · Option (Right to Buy) | +126,000 | 126,000 | ||
| 2021-01-01 | Taspolatoglu Suha Director | Grant or award · Option (Right to Buy) | +126,000 | 126,000 | ||
| 2021-01-01 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +1,757,000 | 1,757,000 |
Page 13 of 27 · 525 trades